Výsledky vyhledávání - "Sumyeong Park"

Akademický článek

Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release

Autor: Eunhee Lee, Yong-Gyu Son, Shinai Lee, Yangmi Lim, Jonghwa Won, Sumyeong Park, Jiseon Yoo, Youngil Koh, Dong-Yeop Shin

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)

Background Acute myeloid leukemia (AML) is a type of leukemia in adults with a high mortality rate and poor prognosis. Although targeted therapeutics, chemotherapy, and hematopoietic stem cell transplantation can improve the prognosis, the recurrence

Externí odkaz: https://doaj.org/article/cc1ad51e12d040fa80953ba783a4336c

Zobrazit plný text záznamu

A Novel Asymmetrical Anti-CLL-1×CD3 Bispecific Antibody, ABL602, Induces Potent CLL1-Specific Antitumor Activity with Minimized Sensitization of Pro-Inflammatory Cytokines

Autor: Eun Hee Lee, Yangmi Lim, Hye-Young Park, Sumyeong Park, Jonghwa Won, Shi-Nai Lee

Publikováno v: Blood. 138:2234-2234

Acute myeloid leukemia (AML) is a disease with high incidence of relapse that is originated and maintained from leukemia stem cells (LSCs). Expression of C-type lectin-like molecule-1 (CLL-1; also known as CLEC12A, c-type lectin domain family 12 memb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cca854033b1f59d3c5a3290feea996ef
https://doi.org/10.1182/blood-2021-145274

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání